Payden & Rygel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10K | Sell |
|
|||||
|
2025
Q2 | $598K | Hold |
|
|||||
|
2025
Q1 | $625K | Hold |
|
|||||
|
2024
Q4 | $655K | Sell |
|
|||||
|
2024
Q3 | $9.09M | Buy |
|
|||||
|
2024
Q2 | $839K | Sell |
|
|||||
|
2024
Q1 | $7.5M | Buy |
|
|||||
|
2023
Q4 | $863K | Hold |
|
|||||
|
2023
Q3 | $994K | Buy |
|
|||||
|
2023
Q2 | $208K | Sell |
|
|||||
|
2023
Q1 | $10.2M | Sell |
|
|||||
|
2022
Q4 | $25.3M | Sell |
|
|||||
|
2022
Q3 | $37.3M | Buy |
|
|||||
|
2022
Q2 | $43.7M | Buy |
|
|||||
|
2022
Q1 | $36.5M | Buy |
|
|||||
|
2021
Q4 | $29.3M | Hold |
|
|||||
|
2021
Q3 | $21.4M | Hold |
|
|||||
|
2021
Q2 | $19.4M | Sell |
|
|||||
|
2021
Q1 | $18.1M | Buy |
|
|||||
|
2020
Q4 | $18M | Sell |
|
|||||
|
2020
Q3 | $18.7M | Buy |
|
|||||
|
2020
Q2 | $15.9M | Hold |
|
|||||
|
2020
Q1 | $15.9M | Sell |
|
|||||
|
2019
Q4 | $33.6M | Sell |
|
|||||
|
2019
Q3 | $31M | Sell |
|
|||||
|
2019
Q2 | $38.3M | Buy |
|
|||||
|
2019
Q1 | $34.3M | Sell |
|
|||||
|
2018
Q4 | $35.3M | Buy |
|
|||||
|
2018
Q3 | $31.9M | Sell |
|
|||||
|
2018
Q2 | $26.9M | Sell |
|
|||||
|
2018
Q1 | $26.5M | Buy |
|
|||||
|
2017
Q4 | $20.1M | Hold |
|
|||||
|
2017
Q3 | $19.8M | Hold |
|
|||||
|
2017
Q2 | $18.7M | Buy |
|
|||||
|
2017
Q1 | $18.6M | Hold |
|
|||||
|
2016
Q4 | $17.6M | Buy |
|
|||||
|
2016
Q3 | $17.2M | Hold |
|
|||||
|
2016
Q2 | $17.9M | Hold |
|
|||||
|
2016
Q1 | $15M | Buy |
|
|||||
|
2015
Q4 | $16.2M | Sell |
|
|||||
|
2015
Q3 | $17.5M | Sell |
|
|||||
|
2015
Q2 | $18.6M | Hold |
|
|||||
|
2015
Q1 | $19.3M | Buy |
|
|||||
|
2014
Q4 | $12.4M | Buy |
|
|||||
|
2014
Q3 | $8.29M | Sell |
|
|||||
|
2014
Q2 | $8.65M | Buy |
|
|||||
|
2014
Q1 | $5.83M | Buy |
|
|||||
|
2013
Q4 | $5.51M | Hold |
|
|||||
|
2013
Q3 | $5.17M | Buy |
|
|||||
|
2013
Q2 | $2.73M | Buy |
|